Immunotherapy for chronic hepatitis B
10.3969/j.issn.1001-5256.2019.11.040
- VernacularTitle:慢性乙型肝炎的免疫治疗
- Author:
Xiaomin WU
1
;
Qiaoyun TONG
;
Wei LIU
Author Information
1. Department of Gastroenterology, The First Clinical Medical College of China Three Gorges University, Yichang, Hubei 443003, China
- Publication Type:Research Article
- Keywords:
hepatitis B, chronic;
immunotherapy, active;
immunization, passive
- From:
Journal of Clinical Hepatology
2019;35(11):2569-2572
- CountryChina
- Language:Chinese
-
Abstract:
Although current direct anti-hepatitis B virus (HBV) drugs have good effects in controlling viral replication and limiting the progression to liver cirrhosis, there is still a long way to go in the treatment of chronic hepatitis B (CHB). Immune tolerance and immune dysfunction may be the two most important immunopathogenic factors. With reference to the development of new strategies and new drugs for anti-HBV immunotherapy and the latest research findings around the world, this article reviews the research advances in immunotherapy for CHB in recent years.
